查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1372919

家禽疫苗市场 - 全球产业规模、份额、趋势、机会和预测，2018-2028按应用、按产品、按疾病类型、按地区、按竞争预测和机会细分，2018-2028F

Poultry Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application, By Product, By Disease Type, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年，全球家禽疫苗市场价值为17.3 亿美元，预计到2028 年，预测期内将出现令人瞩目的增长，复合年增长率为6.90%。全球家禽疫苗市场是全球动物保健行业中充满活力且重要的部分。该市场主要围绕着疫苗的开发、生产和分销，旨在保护家禽（包括鸡和火鸡）免受一系列疾病的侵害。家禽养殖是全球食品供应链的重要组成部分，因此有效疫苗的供应对于维持家禽群的健康和生产力至关重要。

主要市场驱动因素

全球家禽消费量上升

市场概况
预测期 2024-2028
2022 年市场规模 17.3亿美元
2028 年市场规模 26亿美元
2023-2028 年复合年增长率 6.90%
成长最快的细分市场 减毒活疫苗
最大的市场 北美洲

由于全球对鸡肉和火鸡等家禽产品的需求不断增长，全球家禽业正在飙升至新的高度。人们对家禽的需求不断增长，不仅证明了饮食偏好的变化，也是全球家禽疫苗市场扩张的主要动力。家禽，尤其是鸡肉，因其价格实惠、用途广泛和瘦肉蛋白含量而成为全世界饮食的主食。随着全球人口激增和城市化进程的持续，对家禽产品的需求激增。据业界报告称，家禽消费呈稳定上升趋势，没有放缓的迹象。需求的激增与健康和可持续的家禽业的需求直接相关。家禽业不仅是蛋白质的重要来源，也是全球经济的重要贡献者。然而，它极易受到疾病爆发的影响，导致家禽大量死亡、供应链中断并造成重大经济损失。禽流感、新城疫和球虫病等疾病对家禽养殖场构成持续威胁。因此，保障家禽健康已成为该产业持续成长的当务之急。家禽疫苗是预防和管理疾病爆发的基本工具。它们提供了一种经济高效且人道的方式来保护家禽群免受各种疾病的侵害。透过给禽类接种疫苗，农民可以降低发病率和死亡率，确保家禽产品的持续健康供应。疫苗在预防疾病爆发方面的可靠性是其在家禽业中越来越多采用的驱动力。随着全球家禽消费量持续成长，家禽养殖户和生产者越来越意识到疾病预防的重要性。为了满足对家禽产品不断增长的需求并降低疾病爆发的风险，农民越来越多地实施疫苗接种计划。这些计划涉及在家禽生命週期的各个阶段对其进行疫苗接种，以增强其免疫力和整体健康。家禽消费的激增促使家禽疫苗产业对研发进行了大量投资。公司正致力于开发更有效和创新的疫苗来对抗更广泛的疾病。这些进步包括新型疫苗配方、改进的递送方法以及针对当地疾病特征量身定制的区域特异性疫苗。

预防家禽动物疾病爆发

全球家禽业正面临前所未有的挑战，因为它努力满足对家禽产品不断增长的需求。家禽群中疾病爆发可能是灾难性的，导致重大经济损失和供应链中断。为了应对这项威胁，全球家禽疫苗市场已成为保障家禽健康的关键参与者。家禽，包括鸡和火鸡，非常容易感染一系列疾病，包括禽流感、新城疫、传染性支气管炎和球虫病。这些疾病可在鸡群内迅速传播，导致死亡率上升、生产效率下降，并为家禽养殖户带来巨大的经济损失。预防这些疾病对于确保家禽的健康和生产力至关重要。家禽疫苗是预防和管理家禽疾病爆发的关键工具。这些疫苗经过专门配製，可以刺激鸟类的免疫系统，使其能够抵抗病原体。透过给家禽动物接种疫苗，农民可以降低疾病传播的风险，并将疫情的影响降至最低，从而使鸡群更健康，家禽产品供应更可靠。家禽疾病爆发的经济影响是深远的。损失不仅包括鸟类死亡的直接成本，还包括与疾病控制措施相关的费用，例如增加的药物使用、检疫程序和额外的劳动成本。此外，供应链的中断可能导致价格波动和市场上家禽产品的供应量减少。农民和家禽生产者越来越认识到疫苗接种计划在预防疾病爆发方面的价值。这些计划涉及对处于生命週期各个阶段的家禽群进行系统性疫苗接种。随着人们对疾病预防重要性的认识不断增强，越来越多的农民开始投资疫苗接种计划，作为保护其投资并确保家禽产品持续供应的主动策略。全球家禽业正在扩张，特别是在新兴市场，城市化、收入增加和饮食习惯的改变正在推动家禽消费的增加。随着家禽业的发展，有效的疾病预防策略的需求也在增加。家禽疫苗是这些策略的组成部分，有助于产业的整体健康和永续发展。

疫苗技术的进步

全球家禽疫苗市场正在经历重大转变，这在很大程度上是由疫苗技术突破性进步所推动的。家禽养殖是食品工业的基石，面临着疾病爆发和满足世界对家禽产品不断增长的需求的日益严峻的挑战。疫苗技术进步最显着的好处之一是家禽疫苗效力的增强。传统疫苗已被更复杂的配方所取代，这些配方可以用更少的剂量提供更持久的保护。这些新一代疫苗可刺激家禽更强、更持久的免疫反应，降低疾病爆发的可能性并改善鸡群的整体健康。现代疫苗技术可以开发针对特定疾病或病原体菌株的高度特异性疫苗。这种精确度对于解决影响家禽的各种疾病至关重要。透过针对特定病原体，疫苗可以更好地预防更广泛的疾病，包括禽流感、新城疫和球虫病。疫苗输送方法的进步使家禽养殖户的疫苗接种变得更加方便和有效率。传统的注射疫苗正在接受口服疫苗、雾化疫苗和载有疫苗的诱饵等创新方法的补充。这些方法简化了疫苗管理，减少了对鸟类的压力，并最大限度地减少了对熟练劳动力的需求，有助于节省成本和提高采用率。新的疫苗技术旨在更有效地刺激鸟类的免疫系统。佐剂和输送系统经过改进，可引发强大且持续的免疫反应。这可确保家禽对疾病产生强大的免疫力，从而减少与疾病相关的损失并提高鸡群的生产力。为了应对特定区域的疾病挑战，疫苗製造商正在开发客製化的区域疫苗。这些疫苗考虑了特定地理区域的流行疾病和病毒株，为家禽养殖户提供针对其独特疾病特征的客製化解决方案。这种客製化可以实现更有效的疾病预防策略。

扩大新兴市场的家禽业

全球家禽业正在经历显着的扩张，其中大部分成长是由亚太、拉丁美洲和非洲等地区的新兴市场所推动的。随着这些市场家禽生产和消费的激增，对有效疾病预防措施，特别是家禽疫苗的需求不断增加。由于快速城市化、可支配收入增加和饮食偏好变化等因素，新兴经济体正成为全球家禽业的关键参与者。这些地区正在经历对鸡肉和火鸡等富含蛋白质的家禽产品的更高消费的转变。因此，新兴市场正稳步崛起，成为全球家禽业的主要贡献者。新兴市场不断扩大的家禽业的特征是家禽产量大幅增加。家禽养殖场的规模和复杂性不断扩大，采用了现代农业实践和技术。为了满足对家禽产品不断增长的需求，这些农场正在管理更大的鸡群，这反过来又增加了疾病爆发的可能性。新兴市场家禽业的快速成长伴随着新的和不断变化的疾病挑战。禽流感、新城疫、球虫病等家禽疾病对家禽健康及生产有重大威胁。这些疾病可以在人口密集的家禽养殖场中迅速传播，导致严重的经济损失和潜在的粮食安全问题。家禽疫苗是预防和管理家禽疾病爆发不可或缺的工具。它们提供了一种经济高效且人道的方法来保护家禽免受多种疾病的侵害。随着新兴市场努力应对因家禽生产集约化而增加的疾病风险，疫苗在维持鸡群健康和确保粮食供应方面的重要性怎么强调也不为过。

主要市场挑战

疾病的复杂性和变异性

家禽疫苗市场面临的最重要挑战之一是家禽疾病的复杂性和变异性。家禽容易受到多种病原体的影响，包括病毒、细菌和寄生虫，每种病原体都有不同的菌株和突变。开发针对这些不断进化的病原体提供全面保护的疫苗可能是一项艰鉅的任务。

监管障碍

疫苗的生产和分销须遵守严格的监管要求，以确保安全性和有效性。对于疫苗製造商来说，满足这些监管标准可能是一个成本高昂且耗时的过程。任何偏离这些标准的行为都可能导致疫苗批准和市场准入的延迟，从而增加财务负担。

冷链管理

在整个分配过程中保持疫苗的完整性至关重要。家禽疫苗通常对温度波动敏感，储存不当可能会使其失效。在基础设施和资源有限的地区，维持可靠的疫苗冷链可能是一项重大挑战。

疫苗抗药性和合规性

疫苗抗药性，即病原体对疫苗产生抗药性，越来越受到人们的关注。此外，确保家禽养殖户遵守建议的疫苗接种时间表和方案可能具有挑战性。疫苗接种不一致可能会导致保护缺口和疾病爆发。

主要市场趋势

精准疫苗接种

精准疫苗接种是家禽疫苗市场的发展趋势。这种方法涉及根据个体鸡群或禽舍的具体需求量身定制疫苗接种计划。透过考虑年龄、健康状况和疾病暴露等因素，精准疫苗接种旨在优化疫苗功效，同时最大限度地降低成本。先进的资料分析和监测系统被用来有效实施精准疫苗接种策略。

免疫增强佐剂

疫苗佐剂的创新即将到来。佐剂是一种添加到疫苗中以增强人体免疫反应的物质。新型佐剂的开发可以提高家禽疫苗的功效，从而更好地预防更广泛的疾病。这些佐剂还可以减少多次加强疫苗接种的需要，提高疫苗接种计画的便利性和成本效益。

DNA疫苗

DNA 疫苗因其在家禽疫苗市场的潜力而受到关注。这些疫苗使用遗传物质 (DNA) 来刺激免疫系统。 DNA疫苗因其安全性、稳定性和快速开发潜力而具有优势。随着该领域研究的进展，DNA 疫苗可能成为家禽疾病传统疫苗的可行替代品。

疫苗输送创新

疫苗输送系统的进步将彻底改变家禽疫苗市场。除了传统的注射疫苗外，口服疫苗、雾化疫苗和载有疫苗的诱饵等新型递送方法也正在开发中。这些方法简化了疫苗接种，减轻了鸟类的压力，并提高了疫苗接种计画的效率。

细分市场洞察

产品洞察

2022年，减毒活疫苗类别占据了收入的最大部分。与其他疫苗品种相比，这些类型的疫苗能够刺激免疫系统产生更多数量的抗体。此外，它们的保护作用持续时间更长，可以预防传染性支气管炎、传染性法氏囊病和新城疫等禽类疾病。此外，为对抗上述疾病的爆发，特别是在疫苗接种领域，不断增加的研发力度也推动了这一领域的成长。

疾病类型见解

2022年，与沙门氏菌疾病相关的业务占收入的最大部分。在预测期内，掉蛋综合症（EDS）领域预计将表现出最快的复合年增长率（CAGR）。这种增长可归因于家禽中沙门氏菌和产蛋综合症疾病的高流行。沙门氏菌疫苗的主要类型包括减毒沙门氏菌菌株，它们作为口服载体疫苗有效且安全地发挥作用，透过表达外源抗原来预防坏死性肠炎。

市场参与者积极参与新疫苗的研发工作，旨在扩大其影响力和市场份额。例如，Venkys India 提供一系列家禽疫苗，包括沙门氏菌多价灭活疫苗，旨在预防和控制蛋鸡、种鸡和肉鸡的沙门氏菌病。 KM Biologics 的产品组合中包含 OILVAX EDS-76，可有效对抗掉蛋症候群。

区域洞察

2022年，欧洲在收入份额方面占据主导地位。这可以归因于多种因素，包括主要行业参与者的存在、不断努力打击在动物中使用抗菌剂以及对人畜共患疾病的担忧不断升级。世界卫生组织 (WHO) 已将抗菌素抗药性视为重大的公共卫生风险。各种公共卫生组织和兽医监管机构，例如兽医用药品委员会 (CVMP)，负责实施欧盟统一健康行动计划，以解决抗菌素抗药性问题。他们透过制定《兽药条例》中概述的政策来做到这一点。

另一方面，亚太地区预计在预测期内复合年增长率最快。这可以归因于人们对家禽疫苗的认识不断提高、疫苗接种意识计划的激增以及其他因素，例如政府倡议的加强和畜牧业实践的显着进步。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球家禽疫苗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按应用（肉鸡、蛋鸡、种鸡）
    • 副产品（减毒活疫苗、不活化疫苗、次单位疫苗、DNA疫苗、重组疫苗）
    • 依疾病类型（传染性支气管炎、传染性法氏囊病、传染性喉气管炎、滴蛋症候群、腺病毒、鸭病毒性肠炎、包涵体肝炎、沙门氏菌等）
    • 按地区
    • 按公司划分 (2022)
  • 产品市场地图
    • 按应用
    • 按产品分类
    • 依疾病类型
    • 按地区

第 6 章：北美家禽疫苗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按应用（肉鸡、蛋鸡、种鸡）
    • 副产品（减毒活疫苗、不活化疫苗、次单位疫苗、DNA疫苗、重组疫苗）
    • 依疾病类型（传染性支气管炎、传染性法氏囊病、传染性喉气管炎、滴蛋症候群、腺病毒、鸭病毒性肠炎、包涵体肝炎、沙门氏菌等）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲家禽疫苗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按应用（肉鸡、蛋鸡、种鸡）
    • 副产品（减毒活疫苗、不活化疫苗、次单位疫苗、DNA疫苗、重组疫苗）
    • 依疾病类型（传染性支气管炎、传染性法氏囊病、传染性喉气管炎、滴蛋症候群、腺病毒、鸭病毒性肠炎、包涵体肝炎、沙门氏菌等）
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章：亚太地区家禽疫苗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按应用（肉鸡、蛋鸡、种鸡）
    • 副产品（减毒活疫苗、不活化疫苗、次单位疫苗、DNA疫苗、重组疫苗）
    • 依疾病类型（传染性支气管炎、传染性法氏囊病、传染性喉气管炎、滴蛋症候群、腺病毒、鸭病毒性肠炎、包涵体肝炎、沙门氏菌等）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 9 章：南美洲家禽疫苗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按应用（肉鸡、蛋鸡、种鸡）
    • 副产品（减毒活疫苗、不活化疫苗、次单位疫苗、DNA疫苗、重组疫苗）
    • 依疾病类型（传染性支气管炎、传染性法氏囊病、传染性喉气管炎、滴蛋症候群、腺病毒、鸭病毒性肠炎、包涵体肝炎、沙门氏菌等）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲家禽疫苗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按应用（肉鸡、蛋鸡、种鸡）
    • 副产品（减毒活疫苗、不活化疫苗、次单位疫苗、DNA疫苗、重组疫苗）
    • 依疾病类型（传染性支气管炎、传染性法氏囊病、传染性喉气管炎、滴蛋症候群、腺病毒、鸭病毒性肠炎、包涵体肝炎、沙门氏菌等）
    • 按国家/地区
  • MEA：国家分析
    • 南非家禽疫苗
    • 沙乌地阿拉伯家禽疫苗
    • 阿联酋家禽疫苗
    • 科威特家禽疫苗

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • Boehringer Ingelheim GmbH
    • Zoetis Inc
    • Elanco LLC
    • Intervet Inc
    • Hester Biosciences Ltd
    • Vaxxinova GmbH
    • Venky's India Ltd
    • Laboratorios Calier SA
    • KM Biologics Co Ltd
    • Phibro Animal Health Corp

第 15 章：策略建议

第 16 章：关于我们与免责声明

简介目录
Product Code: 16323

Global Poultry Vaccines Market has valued at USD 1.73 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.90% through 2028. The Global Poultry Vaccines Market is a dynamic and essential segment of the global animal healthcare industry. This market primarily revolves around the development, production, and distribution of vaccines designed to safeguard poultry, including chickens and turkeys, from a range of diseases. Poultry farming is a critical component of the global food supply chain, making the availability of effective vaccines crucial for maintaining the health and productivity of poultry flocks.

Key Market Drivers

Rising Global Poultry Consumption

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.73 Billion
Market Size 2028USD 2.60 Billion
CAGR 2023-20286.90%
Fastest Growing SegmentAttenuated Live Vaccine
Largest MarketNorth America

The global poultry industry is soaring to new heights, fueled by an ever-increasing global demand for poultry products such as chicken and turkey. This growing appetite for poultry is not only a testament to shifting dietary preferences but also a major driver for the expansion of the global poultry vaccines market. Poultry, particularly chicken, has become a staple in diets worldwide due to its affordability, versatility, and lean protein content. As global populations burgeon and urbanization continues, the demand for poultry products has surged. According to industry reports, poultry consumption is on a steady upward trajectory, with no signs of slowing down. This surge in demand directly correlates with the need for a healthy and sustainable poultry industry. The poultry industry is not only a vital source of protein but also a significant contributor to the global economy. However, it is highly susceptible to disease outbreaks that can decimate poultry flocks, disrupt supply chains, and incur substantial economic losses. Diseases such as avian influenza, Newcastle disease, and coccidiosis pose constant threats to poultry farms. Consequently, safeguarding poultry health has become imperative for the industry's sustained growth. Poultry vaccines are a fundamental tool in preventing and managing disease outbreaks. They offer a cost-effective and humane way to protect poultry flocks from various diseases. By vaccinating birds, farmers can reduce the morbidity and mortality rates, ensuring a consistent and healthy supply of poultry products. The reliability of vaccines in preventing disease outbreaks is a driving force behind their increasing adoption in the poultry industry. As global poultry consumption continues to rise, poultry farmers and producers are becoming more conscious of the importance of disease prevention. To meet the growing demand for poultry products and mitigate the risk of disease outbreaks, farmers are increasingly implementing vaccination programs. These programs involve the administration of vaccines to poultry flocks at various stages of their lifecycle, bolstering their immunity and overall health. The surge in poultry consumption has prompted significant investments in research and development within the poultry vaccines industry. Companies are focusing on developing more efficacious and innovative vaccines to combat a broader spectrum of diseases. These advancements include novel vaccine formulations, improved delivery methods, and region-specific vaccines tailored to local disease profiles.

Preventing Disease Outbreaks in Poultry Animals

The global poultry industry is facing unprecedented challenges as it strives to meet the ever-growing demand for poultry products. Disease outbreaks in poultry flocks can be catastrophic, resulting in significant economic losses and disruptions to the supply chain. In response to this threat, the global poultry vaccines market has emerged as a crucial player in safeguarding poultry health. Poultry, including chickens and turkeys, are highly susceptible to a range of diseases, including avian influenza, Newcastle disease, infectious bronchitis, and coccidiosis. These diseases can spread rapidly within flocks, leading to increased mortality rates, decreased production efficiency, and substantial financial losses for poultry farmers. Preventing these diseases is paramount to ensuring the health and productivity of poultry animals. Poultry vaccines are pivotal tools in preventing and managing disease outbreaks in poultry populations. These vaccines are specifically formulated to stimulate the bird's immune system, equipping them to fend off pathogens. By vaccinating poultry animals, farmers can reduce the risk of disease transmission and minimize the impact of outbreaks, resulting in healthier flocks and a more reliable supply of poultry products. The economic ramifications of disease outbreaks in poultry are profound. Losses can encompass not only the direct costs of bird mortality but also the expenses associated with disease control measures, such as increased medication usage, quarantine procedures, and additional labor costs. Moreover, the disruption in the supply chain can lead to price fluctuations and reduced availability of poultry products in the market. Farmers and poultry producers are increasingly recognizing the value of vaccination programs in preventing disease outbreaks. These programs involve the systematic administration of vaccines to poultry flocks at various stages of their lifecycle. As awareness of the importance of disease prevention grows, more farmers are investing in vaccination programs as a proactive strategy to protect their investments and ensure a consistent supply of poultry products. The global poultry industry is expanding, particularly in emerging markets where urbanization, rising incomes, and changing dietary habits are driving increased poultry consumption. As the poultry industry grows, so does the need for effective disease prevention strategies. Poultry vaccines are an integral part of these strategies, contributing to the overall health and sustainability of the industry.

Advancements in Vaccine Technology

The global poultry vaccines market is undergoing a significant transformation, driven in large part by groundbreaking advancements in vaccine technology. Poultry farming, a cornerstone of the food industry, faces ever-increasing challenges from disease outbreaks and the need to meet the world's growing demand for poultry products. One of the most notable benefits of advancements in vaccine technology is the enhanced efficacy of poultry vaccines. Traditional vaccines have given way to more sophisticated formulations that can provide longer-lasting protection with fewer doses. These next-generation vaccines stimulate a stronger and more sustained immune response in poultry, reducing the likelihood of disease outbreaks and improving overall flock health. Modern vaccine technology allows for the development of highly specific vaccines tailored to target particular diseases or strains of pathogens. This level of precision is essential in addressing the diverse range of diseases that affect poultry. By targeting specific pathogens, vaccines can offer better protection against a broader spectrum of diseases, including avian influenza, Newcastle disease, and coccidiosis. Advancements in vaccine delivery methods have made vaccination more convenient and efficient for poultry farmers. Traditional injection-based vaccines are being complemented by innovative approaches such as oral vaccines, aerosolized vaccines, and vaccine-laden bait. These methods simplify vaccine administration, reduce stress on birds, and minimize the need for skilled labor, contributing to cost savings and increased adoption rates. New vaccine technologies are designed to stimulate the bird's immune system more effectively. Adjuvants and delivery systems have been refined to trigger a robust and sustained immune response. This ensures that poultry develop strong immunity to diseases, resulting in fewer disease-related losses and more productive flocks. To address region-specific disease challenges, vaccine manufacturers are developing customized regional vaccines. These vaccines take into account the prevalent diseases and strains in a specific geographic area, providing poultry farmers with tailored solutions for their unique disease profiles. This customization allows for more effective disease prevention strategies.

Expanding Poultry Industry in Emerging Markets

The global poultry industry is experiencing a remarkable expansion, and much of this growth is driven by emerging markets in regions like Asia-Pacific, Latin America, and Africa. As these markets witness a surge in poultry production and consumption, the demand for effective disease prevention measures, particularly poultry vaccines, is on the rise. Emerging economies are becoming key players in the global poultry industry due to factors such as rapid urbanization, increasing disposable incomes, and changing dietary preferences. These regions are experiencing a shift towards a higher consumption of protein-rich poultry products like chicken and turkey. As a result, emerging markets are steadily emerging as major contributors to the global poultry industry. The expanding poultry industry in emerging markets is characterized by substantial increases in poultry production. Poultry farms are growing in size and sophistication, adopting modern farming practices and technology. With the goal of meeting the rising demand for poultry products, these farms are managing larger flocks, which in turn increases the potential for disease outbreaks. The rapid growth of the poultry industry in emerging markets is accompanied by new and evolving disease challenges. Poultry diseases, such as avian influenza, Newcastle disease, and coccidiosis, pose significant threats to poultry health and production. These diseases can spread rapidly within densely populated poultry farms, leading to severe economic losses and potential food security concerns. Poultry vaccines are indispensable tools in preventing and managing disease outbreaks in poultry flocks. They offer a cost-effective and humane means of protecting poultry from a wide range of diseases. As emerging markets grapple with increased disease risks due to intensified poultry production, the importance of vaccines in maintaining flock health and securing food supplies cannot be overstated.

Key Market Challenges

Disease Complexity and Variability

One of the foremost challenges in the poultry vaccines market is the complexity and variability of poultry diseases. Poultry are susceptible to a wide range of pathogens, including viruses, bacteria, and parasites, each with different strains and mutations. Developing vaccines that provide comprehensive protection against these evolving pathogens can be a formidable task.

Regulatory Hurdles

The production and distribution of vaccines are subject to stringent regulatory requirements to ensure safety and efficacy. Meeting these regulatory standards can be a costly and time-consuming process for vaccine manufacturers. Any deviations from these standards can lead to delays in vaccine approval and market entry, increasing the financial burden.

Cold Chain Management

Maintaining the integrity of vaccines throughout the distribution process is critical. Poultry vaccines are often sensitive to temperature fluctuations, and improper storage can render them ineffective. In regions with limited infrastructure and resources, maintaining a reliable cold chain for vaccines can be a significant challenge.

Vaccine Resistance and Compliance

Vaccine resistance, where pathogens develop resistance to vaccines, is a growing concern. Additionally, ensuring that poultry farmers adhere to recommended vaccination schedules and protocols can be challenging. Inconsistent vaccine administration can lead to gaps in protection and disease outbreaks.

Key Market Trends

Precision Vaccination

Precision vaccination is a trend gaining momentum in the poultry vaccines market. This approach involves tailoring vaccination programs to the specific needs of individual flocks or poultry houses. By considering factors such as age, health status, and disease exposure, precision vaccination aims to optimize vaccine efficacy while minimizing costs. Advanced data analytics and monitoring systems are being employed to implement precision vaccination strategies effectively.

Immune-Boosting Adjuvants

Innovations in vaccine adjuvants are on the horizon. Adjuvants are substances added to vaccines to enhance the body's immune response. The development of novel adjuvants can improve the efficacy of poultry vaccines, enabling better protection against a wider range of diseases. These adjuvants may also reduce the need for multiple booster vaccinations, enhancing the convenience and cost-effectiveness of vaccination programs.

DNA Vaccines

DNA vaccines are gaining attention for their potential in the poultry vaccines market. These vaccines use genetic material (DNA) to stimulate the immune system. DNA vaccines are advantageous due to their safety, stability, and potential for rapid development. As research in this area progresses, DNA vaccines may become a viable alternative to traditional vaccines for poultry diseases.

Vaccine Delivery Innovations

Advancements in vaccine delivery systems are set to revolutionize the poultry vaccines market. In addition to traditional injection-based vaccines, novel delivery methods such as oral vaccines, aerosolized vaccines, and vaccine-laden bait are being developed. These methods simplify vaccine administration, reduce stress on birds, and increase the efficiency of vaccination programs.

Segmental Insights

Product Insights

In 2022, the category of attenuated live vaccines secured the largest portion of revenue. These types of vaccines are capable of stimulating the immune system to generate a higher quantity of antibodies compared to other vaccine varieties. Additionally, their protective effects last longer and guard against avian illnesses like infectious bronchitis, infectious bursal disease, and Newcastle disease. Furthermore, the growth of this segment is being boosted by the increasing research and development efforts, particularly in the field of vaccination, to combat outbreaks of the mentioned diseases.

In the upcoming years, the segments of recombinant vaccines and inactivated vaccines are expected to experience rapid growth. This is primarily driven by advancements in product development and the safety advantages offered by inactivated and recombinant vaccines when compared to live attenuated vaccines. For instance, Zoetis has an extensive range of poultry vaccines in its Poulvac brand, with poultry accounting for 18% of the company's livestock revenue in 2020.

Disease Type Insights

In 2022, the segment related to salmonella diseases accounted for the largest portion of revenue. Over the forecast period, the Egg Drop Syndrome (EDS) segment is anticipated to exhibit the most rapid Compound Annual Growth Rate (CAGR). This growth can be attributed to the high prevalence of Salmonella and Egg Drop Syndrome diseases among poultry animals. The predominant type of vaccine for salmonella consists of attenuated Salmonella strains, which function effectively and safely as oral carrier vaccines for preventing necrotic enteritis by expressing foreign antigens.

Market participants are actively engaged in research and development efforts to introduce new vaccines, aiming to expand their presence and market share. For instance, Venkys India offers a range of poultry vaccines, including the Salmonella polyvalent inactivated vaccine, designed to prevent and manage salmonellosis in layers, breeders, and broilers. KM Biologics includes OILVAX EDS-76 in its portfolio, which effectively combats egg drop syndrome.

Regional Insights

In 2022, Europe dominated in terms of revenue share. This can be attributed to several factors, including the presence of major industry players, growing efforts to combat the use of antimicrobial agents in animals, and escalating concerns about zoonotic diseases. The World Health Organization (WHO) has recognized antimicrobial resistance as a significant public health risk. Various public health organizations and veterinary regulatory bodies, such as the Committee for Medicinal Products for Veterinary Use (CVMP), are responsible for implementing the EU's One Health Action Plan to address antimicrobial resistance. They do this by enacting policies outlined in the Veterinary Medicines Regulation.

On the other hand, the Asia Pacific region is projected to experience the most rapid CAGR during the forecast period. This can be attributed to the increasing awareness about poultry vaccines, a surge in vaccination awareness programs, and other factors such as heightened government initiatives and notable advancements in animal husbandry practices.

Key Market Players

  • Boehringer Ingelheim GmbH
  • Zoetis Inc
  • Elanco LLC
  • Intervet Inc
  • Hester Biosciences Ltd
  • Vaxxinova GmbH
  • Venky's India Ltd
  • Laboratorios Calier SA
  • KM Biologics Co Ltd
  • Phibro Animal Health Corp

Report Scope:

In this report, the Global Poultry Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Vaccines Market, By Application:

  • Broiler
  • Layer
  • Breeder

Poultry Vaccines Market, By Product:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Poultry Vaccines Market, By Disease Type:

  • Infectious Bronchitis
  • Infectious Bursal Diseases
  • Infectious Laryngotracheitis
  • Egg Drop Syndrome
  • Adenovirus
  • Duck Viral Enteritis
  • Inclusion Body Hepatitis
  • Salmonella
  • Others

Poultry Vaccines Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.

Available Customizations:

  • Global Poultry Vaccines market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Poultry Vaccines Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Broiler, Layer, Breeder)
    • 5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Application
    • 5.3.2. By Product
    • 5.3.3. By Disease Type
    • 5.3.4. By Region

6. North America Poultry Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application (Broiler, Layer, Breeder)
    • 6.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 6.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Poultry Vaccines Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Disease Type
    • 6.3.2. Canada Poultry Vaccines Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Disease Type
    • 6.3.3. Mexico Poultry Vaccines Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Disease Type

7. Europe Poultry Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application (Broiler, Layer, Breeder)
    • 7.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 7.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Poultry Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Disease Type
    • 7.3.2. United Kingdom Poultry Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Disease Type
    • 7.3.3. France Poultry Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Disease Type
    • 7.3.4. Italy Poultry Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Disease Type
    • 7.3.5. Spain Poultry Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Poultry Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application (Broiler, Layer, Breeder)
    • 8.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 8.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Poultry Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Disease Type
    • 8.3.2. Japan Poultry Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Disease Type
    • 8.3.3. India Poultry Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Disease Type
    • 8.3.4. Australia Poultry Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Disease Type
    • 8.3.5. South Korea Poultry Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Disease Type

9. South America Poultry Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application (Broiler, Layer, Breeder)
    • 9.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 9.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Poultry Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Disease Type
    • 9.3.2. Argentina Poultry Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Disease Type
    • 9.3.3. Colombia Poultry Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Poultry Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application (Broiler, Layer, Breeder)
    • 10.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 10.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Poultry Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Disease Type
    • 10.3.2. Saudi Arabia Poultry Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Disease Type
    • 10.3.3. UAE Poultry Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Disease Type
    • 10.3.4. Kuwait Poultry Vaccines Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Application
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Disease Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Boehringer Ingelheim GmbH
    • 14.6.2. Zoetis Inc
    • 14.6.3. Elanco LLC
    • 14.6.4. Intervet Inc
    • 14.6.5. Hester Biosciences Ltd
    • 14.6.6. Vaxxinova GmbH
    • 14.6.7. Venky's India Ltd
    • 14.6.8. Laboratorios Calier SA
    • 14.6.9. KM Biologics Co Ltd
    • 14.6.10. Phibro Animal Health Corp

15. Strategic Recommendations

16. About Us & Disclaimer